Study to Evaluate the Effect of Erenumab on Blood Pressure When Given Concomitantly With Subcutaneous Sumatriptan

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

February 22, 2016

Primary Completion Date

August 11, 2016

Study Completion Date

August 11, 2016

Conditions

Healthy Subjects

Interventions

DRUG

Placebo

Administered by intravenous infusion

DRUG

Sumatriptan

Administered by two 6 mg subcutaneous injections 1 hour apart on day 2 and day 5

DRUG

Erenumab

Administered by intravenous infusion

Trial Locations (1)

Research Site, Leuven